New Meds, Trials, and Studies
MAC Lung Infection
Have you been recently/newly diagnosed with a MAC lung infection? MAC is the most common form of
nontuberculous mycobacteria (NTM). NTM are bacteria commonly found in the environment. MAC can
get inside your lungs when you breathe them in and can affect certain people more than others. Most
people who come in contact with MAC do not develop an infection. However, some individuals are at a
greater risk of developing an infection called MAC lung disease. MAC lung disease is a serious condition.
If untreated, it can cause damage to the lungs.
A new study is looking for individuals with newly diagnosed MAC lung disease who may be interested in
participating in a clinical study that is evaluating a drug for potential treatment of MAC lung infections and for the
potential to improve symptoms of MAC lung infection including decreased respiratory discomfort and decreased
fatigue.
Your participation in the study could potentially contribute to advancements in MAC lung disease research.
You can visit
https://www.patientwing.com/ntmstudy-arise-encore-COPD for more information and to see
if
you may qualify.
If you qualify to enroll, and decide to participate, you will be assigned to one of two studies
investigating MAC lung
disease.
LEEP Losartan Effects on Emphysema Progression LEEP is a randomized clinical trial evaluating the effect
of Losartan in helping people
with Chronic Obstructive Pulmonary Disease (COPD) with emphysema – a disease of the lungs. We
are looking for adults 40
years of age or older, current or former smokers, with COPD to join our study. The study is
conducted in different states
across the country.
🚬
Insight COPD Intervention Study In Overweight Patients with COPD We are trying to find out if a program
proven to help people lose a modest
amount of weight and increase their physical activity will improve COPD symptoms for those with a high BMI.
To be in the study, you will
need to have COPD, high BMI, history of smoking, shortness of breath, and be 40 years or
older.
🚬
RETHINC REdefining Therapy IN early COPD The purpose of the RETHINC study is to determine whether
symptomatic current and former smokers
with normal lung function will benefit from the use of bronchodilator therapy currently used to treat patients
who have Chronic Obstructive
Pulmonary Disease (COPD).
Emphysema/COPD Research Registry [PA only] Have COPD, 40 and
up, 10 year smoking history
Pulmonary Fibrosis Click
the
link to find many clinical trials avilable offered for Idiopathic Pulmonary Fibrosis, Cystic Fibrosis,
Pulmonary Fibrosis by Clinicaltrials.gov
COPD Foundation Research Click Research on the main menu
📋 Find
a Clinical
Trial 📋 American Lung Association 📋
Clinical Trials GPS Find Trials by the US State
Center Watch List Find Trials across the
World
ClinicalConnection Find US and International Trials
US NIH ClinicalTrials.gov Searched for trials for COPD, Chronic Obstructive Pulmonary Disease, Lung Disease,
Lungs and more
